Fox 136d
FDA approves first new non-opioid pain pill in 20 years—how it works
The FDA has approved Journavx, a new non-opioid pain medication designed to reduce addiction and overdose risks.
Zacks.com on MSN6d
ANGO Stock Looks Promising on New Ischemia Study for Auryon System
AngioDynamics, Inc. ANGO recently announced the initiation of a clinical study, AMBITION BTK, comparing the Auryon Atherectomy System Used in Combination with Standard Balloon Angioplasty with ...
Pfizer beats Q4, FY '24 earnings estimates, stock down slightly in premarket trading
Pfizer ( PFE) reported fourth quarter and full-year 2024 earnings results Tuesday, narrowly beating Wall Street expectations ...
IPO Watch: Veeda Clinical Research plans to raise ₹185 crore via IPO; refiles draft papers with SEBI
Veeda Clinical Research has refiled its draft red herring prospectus for an IPO with SEBI. Founded in 2004, the company ...
Stockhead on MSN3d
Paradigm closer to phase III clinical trial with appointment of preferred CRO
Paradigm Biopharmaceuticals continues to edge closer towards starting the pivotal phase III trial for its knee osteoarthritis ...
BioSpace2d
The APAC Opportunity: Why Clinical Trials Are Shifting East
APAC offers stability in an increasing challenging global geopolitical environment for clinical stage drug development.
The Australian3d
Paradigm closer to phase III clinical trial with appointment of preferred CRO
Paradigm Biopharmaceuticals has selected Advanced Clinical as the preferred clinical research organisation for the phase III trial for PARA_OA_012. Advanced Clinical has a proven track record in ...
United Therapeutics scores FDA go-ahead for pig organ transplant clinical trial
Silver Spring’s United Therapeutics has scored a regulatory green light to start clinical trials for its genetically modified pig kidneys to be transplanted into humans. It's as significant for the ...